Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treat.
Saved in:
| Title: | Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treat. |
|---|---|
| Authors: | Baumgarten P; Department of Neurosurgery, University Hospital Frankfurt, Goethe University, Frankfurt, Germany. peter.baumgarten@med.uni-jena.de.; Department of Neurosurgery, University Hospital Jena, Friedrich Schiller University, Am Klinikum 1, D-07747, Jena, Germany. peter.baumgarten@med.uni-jena.de., Prange G; Department of Neurosurgery, University Hospital Jena, Friedrich Schiller University, Jena, Germany., Kamp MA; Department of Neurosurgery, University Hospital Jena, Friedrich Schiller University, Jena, Germany.; Centre for Palliative and Neuro-palliative Care, Brandenburg Medical School Theodor Fontane and Faculty of Health Sciences Brandenburg, Campus Rüdersdorf, Rüdersdorf bei Berlin, Germany., Monden D; Department of Neurosurgery, University Hospital Jena, Friedrich Schiller University, Jena, Germany.; Department of Neurosurgery, Hannover Medical School, Hannover, Germany., Neef V; Department of Anesthesiology, Intensive Care Medicine and Pain Therapy, University Hospital Frankfurt, Goethe University, Frankfurt, Germany., Schwarzer F; Department of Neurosurgery, University Hospital Frankfurt, Goethe University, Frankfurt, Germany., Dubinski D; Department of Neurosurgery, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.; Department of Neurosurgery, University Medicine Rostock, Rostock, Germany., Dinc N; Department of Neurosurgery, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.; Department of Neurosurgery, University Hospital Jena, Friedrich Schiller University, Jena, Germany., Weber KJ; Neurological Institute (Edinger Institute), University Hospital Frankfurt, Goethe University, Frankfurt, Germany.; German Cancer Consortium (DKTK), partner site Frankfurt/Mainz, Frankfurt, Germany.; German Cancer Research Center (DKFZ), Heidelberg, Germany.; Frankfurt Cancer Institute (FCI), Goethe University, Frankfurt, Germany.; University Cancer Center (UCT), Goethe University Hospital, Frankfurt, Germany., Czabanka M; Department of Neurosurgery, University Hospital Frankfurt, Goethe University, Frankfurt, Germany., Hattingen E; Department of Neuroradiology, University Hospital Frankfurt, Goethe University, Frankfurt, Germany., Ronellenfitsch MW; Department of Neuro-Oncology, University Hospital Frankfurt - Goethe-University, Frankfurt, Germany., Steinbach JP; Department of Neuro-Oncology, University Hospital Frankfurt - Goethe-University, Frankfurt, Germany., Senft C; Department of Neurosurgery, University Hospital Frankfurt, Goethe University, Frankfurt, Germany.; Department of Neurosurgery, University Hospital Jena, Friedrich Schiller University, Am Klinikum 1, D-07747, Jena, Germany. |
| Source: | Journal of neuro-oncology [J Neurooncol] 2023 Dec; Vol. 165 (3), pp. 509-515. Date of Electronic Publication: 2023 Nov 30. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 8309335 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7373 (Electronic) Linking ISSN: 0167594X NLM ISO Abbreviation: J Neurooncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7373 |
|---|---|
| DOI: | 10.1007/s11060-023-04518-w |
